MT MeipeptGHK-Cu
Ordered GHK-Cu from MT Meipept? Mail in a sample (US only) and let us test it for free.
Test my supplyMT Meipept's strongest evidence is in Retatrutide, where clean identity/purity and newer in-range fills outweigh an early large overfill. Tirzepatide is weaker, with recent +75% and +80% overfills pointing to fill volatility; the record is current but narrow, with limited external corroboration.
MT Meipept’s own terms point to a Texas Amino USA entity while the storefront runs on China-linked infrastructure and Hong Kong contact rails. The full file follows mailbox/residential addresses, copied QC text, and a near-identical sister domain.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including MT Meipept rows.
Cancel anytime
About MT Meipept test results from Finnrick
MT Meipept is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 18 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible MT Meipept peptides in this dataset are GHK-Cu (4 tests), Retatrutide (7 tests) and Tirzepatide (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 18 recent tests.
Ordered GHK-Cu from MT Meipept? Mail in a sample (US only) and let us test it for free.
Test my supply